David Norton - Mallinckrodt Plc Independent Director
| MNKDelisted Stock | USD 0.46 0.02 4.17% |
Director
Mr. David York Norton is Independent Director of the Company. He is chairman of the board of directors of Vivus, Inc., where he was a director since July 2013. Mr. Norton was company group chairman, Global Pharmaceuticals, for Johnson Johnson, a role in which he led and developed the business strategic growth agenda, including the strategy for licensing, acquisitions and divestments, and ensuring alignment with the global strategic functions, research and development and commercial organizations. He retired in 2011 from Johnson Johnson, where his 32year tenure spanned marketing and international country management roles serving as president of the Janssen Pharmaceuticals business in the U.S., group chairman of the Pharmaceuticals Group for Europe, Middle East and Africa, and then for the U.S. and Canada business as well as the role of company group chairman, worldwide commercial and operations, for Johnson Johnsons CNS and virology business. He previously served as a director for INC Research Holdings Inc. and Savient Pharmaceuticals Inc., a pharmaceutical company that filed for bankruptcy in October 2013. Mr. Norton also serves on the board of TB Alliance, a notforprofit organization dedicated to the discovery and development of tuberculosis drugs. Mr. Nortons qualifications to serve on our Board include his significant experience as an executive andor board member of publicly traded pharmaceutical companies. since 2017.
| Age | 67 |
| Tenure | 7 years |
| Phone | 353 1 696 0000 |
| Web | https://www.mallinckrodt.com |
Mallinckrodt Plc Management Efficiency
Mallinckrodt Plc's management efficiency ratios could be used to measure how well Mallinckrodt Plc manages its routine affairs as well as how well it operates its assets and liabilities.Mallinckrodt Plc has 3.07 B in debt with debt to equity (D/E) ratio of 1.44, which is OK given its current industry classification. Mallinckrodt Plc has a current ratio of 2.92, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Note however, debt could still be an excellent tool for Mallinckrodt to invest in growth at high rates of return.
Similar Executives
| Found 7 records | DIRECTOR Age | ||
| David Lazzarato | Canopy Growth Corp | 64 | |
| Jason Dyck | Aurora Cannabis | N/A | |
| Norma Beauchamp | Aurora Cannabis | 59 | |
| Frank Fallwell | SNDL Inc | N/A | |
| Adam Szweras | Aurora Cannabis | 48 | |
| Tyler Burns | Canopy Growth Corp | N/A | |
| Margaret Atkins | Aurora Cannabis | 63 | |
Management Performance
| Return On Equity | -1.11 | |||
| Return On Asset | -0.0029 |
Mallinckrodt Plc Leadership Team
Elected by the shareholders, the Mallinckrodt Plc's board of directors comprises two types of representatives: Mallinckrodt Plc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Mallinckrodt. The board's role is to monitor Mallinckrodt Plc's management team and ensure that shareholders' interests are well served. Mallinckrodt Plc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Mallinckrodt Plc's outside directors are responsible for providing unbiased perspectives on the board's policies.
| CPA CPA, Global Officer | ||
| David Norton, Independent Director | ||
| Hugh ONeill, Executive Vice President and President, Autoimmune and Rare Diseases | ||
| Steven Romano, Executive Vice President and Chief Scientific Officer | ||
| Sigurdur Olafsson, Pres CEO | ||
| Mark Trudeau, CEO and President Director and Member of Portfolio Committee | ||
| Kneeland Youngblood, Independent Director | ||
| Bryan Reasons, Chief Financial Officer, Executive Vice President | ||
| Mark Casey, Executive Vice President and Chief Legal Officer | ||
| JoAnn Reed, Independent Director | ||
| J Carroll, Independent Director | ||
| Lisa French, Ex Officer | ||
| Kassie Harrold, Ex Officer | ||
| Jason Goodson, Exec Devel | ||
| Ian Watkins, Chief Human Resource Officer, Executive Vice President | ||
| Stephen Welch, Ex Generics | ||
| Henriette Nielsen, Ex Officer | ||
| Steven MD, Ex Officer | ||
| Angus Russell, Independent Non-Executive Chairman of the Board | ||
| Paul Carter, Independent Director | ||
| Carlos Paya, Independent Director | ||
| Anne Whitaker, Independent Director | ||
| Mark Tyndall, Chief VP |
Mallinckrodt Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Mallinckrodt Plc a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.11 | |||
| Return On Asset | -0.0029 | |||
| Profit Margin | (0.83) % | |||
| Operating Margin | (0.01) % | |||
| Current Valuation | 2.62 B | |||
| Shares Outstanding | 13.29 M | |||
| Shares Owned By Insiders | 10.09 % | |||
| Shares Owned By Institutions | 96.64 % | |||
| Number Of Shares Shorted | 1.79 M | |||
| Price To Earning | 1.09 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Consideration for investing in Mallinckrodt Stock
If you are still planning to invest in Mallinckrodt Plc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Mallinckrodt Plc's history and understand the potential risks before investing.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |